Therapy with Radiopharmaceuticals

Authors

  • Jörgen Carlsson From the Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala (J. Carlsson, B. Glimelius), Department of Radiation Physics, Sahlgrenska University Hospital, Go teborg (E. ForssellAronsson) and the Department of Radiation Physics, University Hospital, Malmo (S. Mattsson), Sweden
  • Eva Forssell-Aronsson From the Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala (J. Carlsson, B. Glimelius), Department of Radiation Physics, Sahlgrenska University Hospital, Go teborg (E. ForssellAronsson) and the Department of Radiation Physics, University Hospital, Malmo (S. Mattsson), Sweden
  • Bengt Glimelius From the Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala (J. Carlsson, B. Glimelius), Department of Radiation Physics, Sahlgrenska University Hospital, Go teborg (E. ForssellAronsson) and the Department of Radiation Physics, University Hospital, Malmo (S. Mattsson), Sweden
  • Sören Mattsson From the Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala (J. Carlsson, B. Glimelius), Department of Radiation Physics, Sahlgrenska University Hospital, Go teborg (E. ForssellAronsson) and the Department of Radiation Physics, University Hospital, Malmo (S. Mattsson), Sweden

DOI:

https://doi.org/10.1080/028418602321028229

Abstract

In an investigation by the Swedish Cancer Society, an expert group described the present status, critical issues and future aspects and potentials for each of nine major areas of radiation therapy research. The present report deals with therapy with radiopharmaceuticals.

Downloads

Download data is not yet available.

Downloads

Published

2002-01-01

How to Cite

Carlsson, J., Forssell-Aronsson, E., Glimelius, B., & Mattsson, S. (2002). Therapy with Radiopharmaceuticals. Acta Oncologica, 41(7-8), 623–628. https://doi.org/10.1080/028418602321028229